Unmeasurable low vitamin D levels caused by a novel, homozygote loss-of-function variant in the group-specific component gene.

Vitamin D binding protein free hormone hypothesis group-specific component gene hypovitaminosis D vitamin D deficiency

Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
24 May 2024
Historique:
received: 03 02 2024
revised: 12 04 2024
accepted: 17 04 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: aheadofprint

Résumé

A 29-year-old female, born to consanguineous parents, was found with unmeasurable levels of vitamin D (<10 nmol/l) after routine biochemical screening during her first pregnancy. She did not respond to either oral or intramuscular vitamin D supplementation and was an otherwise healthy young woman, with no signs of rickets, osteomalacia, osteoporosis or secondary hyperparathyroidism. Western blot analysis revealed total lack of vitamin D binding protein, and next generation sequencing confirmed a novel, pathogenic homozygote loss-of-function mutation in exon 13 of the group-specific component gene, that encodes the poly A tail for vitamin D binding protein. She was therefore diagnosed with hereditary DBP deficiency, and vitamin D supplementation was diminished to life-long regular vitamin D supplementation (25 micro grams per day). This case is extremely interesting, as it expands our knowledge of vitamin D physiology and supports the free hormone hypothesis, given that the patient was asymptomatic despite no measurable levels of vitamin D.

Identifiants

pubmed: 38788201
pii: 7681868
doi: 10.1093/ejendo/lvae061
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Endocrinology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Rie Harboe Nygaard (R)

Department of Clinical Biochemistry, Aarhus University Hospital, Denmark.

Esben Stistrup Lauritzen (ES)

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark.
Departmen of Internal Medicine, Horsens Regional Hospital, Denmark.

Tanja Sikjær (T)

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark.
Departmen of Internal Medicine, Horsens Regional Hospital, Denmark.

Carsten Schriver Højskov (C)

Department of Clinical Biochemistry, Aarhus University Hospital, Denmark.

Lars Rejnmark (L)

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark.

Holger Jon Møller (H)

Department of Clinical Biochemistry, Aarhus University Hospital, Denmark.
Department of Clinical Medicine, Aarhus University.

Classifications MeSH